U.S. FDA Head Asks Congress For Import-Drug Inspection Funds
This article was originally published in PharmAsia News
Executive Summary
The head of the U.S. FDA broke with the administration to tell Congress his agency needs another $275 million if it is to inspect imported drugs and medical devices. Commissioner Andrew von Eschenbach wrote to a key senator to cite the need for offices in other countries and increased inspections. The funding request is beyond the administration's budget request submitted earlier this year. Since then, FDA has been under pressure to ensure the safety of drug imports in the wake of the tainted heparin scare in China. (Click here for more